RS63500B1 - Jedinjenja imidazo[4,5-d]pirolo[2,3-b]piridina kao inhibitori janus kinaza - Google Patents
Jedinjenja imidazo[4,5-d]pirolo[2,3-b]piridina kao inhibitori janus kinazaInfo
- Publication number
- RS63500B1 RS63500B1 RS20220753A RSP20220753A RS63500B1 RS 63500 B1 RS63500 B1 RS 63500B1 RS 20220753 A RS20220753 A RS 20220753A RS P20220753 A RSP20220753 A RS P20220753A RS 63500 B1 RS63500 B1 RS 63500B1
- Authority
- RS
- Serbia
- Prior art keywords
- pyrrolo
- imidazo
- inhibitors
- pyridine compounds
- janus kinases
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/437—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having nitrogen as a ring hetero atom, e.g. indolizine, beta-carboline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662435609P | 2016-12-16 | 2016-12-16 | |
| US201762592680P | 2017-11-30 | 2017-11-30 | |
| US201762596607P | 2017-12-08 | 2017-12-08 | |
| EP17854175.1A EP3555097B1 (en) | 2016-12-16 | 2017-12-15 | Imidazo[4,5-d]pyrrolo[2,3-b]pyridine compounds as inhibitors of janus kinases |
| PCT/US2017/066744 WO2018112379A1 (en) | 2016-12-16 | 2017-12-15 | Small molecule inhibitors of the jak family of kinases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS63500B1 true RS63500B1 (sr) | 2022-09-30 |
Family
ID=61692222
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RS20220753A RS63500B1 (sr) | 2016-12-16 | 2017-12-15 | Jedinjenja imidazo[4,5-d]pirolo[2,3-b]piridina kao inhibitori janus kinaza |
Country Status (34)
| Country | Link |
|---|---|
| US (5) | US10294226B2 (sr) |
| EP (2) | EP4086256A1 (sr) |
| JP (2) | JP7291077B2 (sr) |
| KR (1) | KR102352462B1 (sr) |
| CN (1) | CN110088105B (sr) |
| AU (3) | AU2017377069B2 (sr) |
| BR (1) | BR112019011968A2 (sr) |
| CA (1) | CA3046965A1 (sr) |
| CL (1) | CL2019001626A1 (sr) |
| CO (1) | CO2019006200A2 (sr) |
| CR (1) | CR20190282A (sr) |
| DK (1) | DK3555097T3 (sr) |
| EC (1) | ECSP19042688A (sr) |
| ES (1) | ES2922379T3 (sr) |
| HR (1) | HRP20220885T1 (sr) |
| HU (1) | HUE059274T2 (sr) |
| IL (1) | IL267275B (sr) |
| JO (1) | JOP20190143B1 (sr) |
| LT (1) | LT3555097T (sr) |
| MD (1) | MD3555097T2 (sr) |
| MX (2) | MX2019007073A (sr) |
| MY (1) | MY196260A (sr) |
| NI (1) | NI201900060A (sr) |
| PE (1) | PE20191105A1 (sr) |
| PH (1) | PH12019501254A1 (sr) |
| PL (1) | PL3555097T3 (sr) |
| PT (1) | PT3555097T (sr) |
| RS (1) | RS63500B1 (sr) |
| SA (1) | SA519402216B1 (sr) |
| SI (1) | SI3555097T1 (sr) |
| TW (1) | TWI777997B (sr) |
| UA (1) | UA125042C2 (sr) |
| WO (1) | WO2018112379A1 (sr) |
| ZA (1) | ZA201904615B (sr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10131663B2 (en) | 2016-10-24 | 2018-11-20 | Astrazeneca Ab | Chemical compounds |
| CA3046965A1 (en) | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Small molecule inhibitors of the jak family of kinases |
| JOP20190144A1 (ar) * | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| TWI831738B (zh) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
| DK3494116T3 (da) | 2017-01-30 | 2020-01-27 | Astrazeneca | Østrogenreceptormodulatorer |
| WO2019241796A1 (en) | 2018-06-15 | 2019-12-19 | Reata Pharmaceuticals, Inc. | Pyrazole and imidazole compounds for inhibition of il-17 and rorgamma |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| US12060340B2 (en) | 2018-06-20 | 2024-08-13 | Reata Pharmaceuticals, Inc | Cysteine-dependent inverse agonists of nuclear receptors ROR-gamma/ROR-gamma-t and methods of treating diseases or disorders therewith |
| US20200338051A1 (en) | 2019-04-24 | 2020-10-29 | Janssen Pharmaceutica Nv | Non-clinical liquid formulations of pan-jak inhibitor |
| AU2020289149B2 (en) * | 2019-06-06 | 2023-05-11 | Hangzhou Highlightll Pharmaceutical Co., Ltd. | Synthesis method of furoimidazopyridine compound, crystal form of furoimidazopyridine compound, and crystal form of salt thereof |
| CN110483514B (zh) * | 2019-09-16 | 2022-06-14 | 启元生物(杭州)有限公司 | 一种氰基取代的环肼衍生物及其应用 |
| CA3166743A1 (en) * | 2020-02-21 | 2021-08-26 | Weiwei Mao | Crystalline forms of jak inhibitor and uses thereof |
| CN114149428B (zh) * | 2020-09-08 | 2023-06-13 | 中国药科大学 | 吡啶并环类化合物及其制备方法、中间体、组合物和应用 |
| JP2024509587A (ja) | 2021-03-11 | 2024-03-04 | ヤンセン ファーマシューティカ エヌ．ベー． | Ｊａｋ媒介性障害の治療に使用するためのｌｏｒｐｕｃｉｔｉｎｉｂ |
| CN113292561A (zh) * | 2021-05-22 | 2021-08-24 | 中国药科大学 | 一种二吡咯并吡啶结构的化合物、制备方法和医药用途 |
| CN114432317A (zh) * | 2021-05-31 | 2022-05-06 | 广州嘉越医药科技有限公司 | 吡咯并嘧啶类化合物的用途 |
| CN113861194B (zh) * | 2021-11-10 | 2022-07-05 | 英维沃化工科技(广州)有限公司 | 一种含吡咯并吡啶双酰胺咪唑类化合物及其制备方法和应用 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6080747A (en) | 1999-03-05 | 2000-06-27 | Hughes Institute | JAK-3 inhibitors for treating allergic disorders |
| EP2251341A1 (en) * | 2005-07-14 | 2010-11-17 | Astellas Pharma Inc. | Heterocyclic Janus kinase 3 inhibitors |
| JP5071374B2 (ja) * | 2005-07-14 | 2012-11-14 | アステラス製薬株式会社 | ヘテロ環ヤヌスキナーゼ３阻害剤 |
| RS54560B1 (sr) | 2008-06-10 | 2016-06-30 | Abbvie Inc. | Triciklična jedinjenja |
| JP2011066747A (ja) * | 2009-09-18 | 2011-03-31 | Panasonic Corp | 弾性波フィルタ |
| WO2011068899A1 (en) | 2009-12-01 | 2011-06-09 | Abbott Laboratories | Novel tricyclic compounds |
| CN104370909B (zh) * | 2009-12-01 | 2018-09-11 | Abbvie 公司 | 三环化合物 |
| TW201129565A (en) | 2010-01-12 | 2011-09-01 | Hoffmann La Roche | Tricyclic heterocyclic compounds, compositions and methods of use thereof |
| EP2534258B1 (en) | 2010-02-10 | 2017-09-20 | Genon Biotechnologies OY | Dual activity kinase domains and uses thereof |
| WO2013007765A1 (en) * | 2011-07-13 | 2013-01-17 | F. Hoffmann-La Roche Ag | Fused tricyclic compounds for use as inhibitors of janus kinases |
| EP2924026A1 (en) * | 2014-03-28 | 2015-09-30 | Novartis Tiergesundheit AG | Aminosulfonylmethylcyclohexanes as JAK inhibitors |
| AU2016267141B2 (en) | 2015-05-28 | 2020-04-16 | Theravance Biopharma R&D Ip, Llc | Naphthyridine compounds as jak kinase inhibitors |
| EP3371332A4 (en) | 2015-11-04 | 2019-04-03 | Mayo Foundation for Medical Education and Research | METHODS AND MATERIALS FOR TREATING AUTOIMMUNE DISEASES |
| US10131663B2 (en) | 2016-10-24 | 2018-11-20 | Astrazeneca Ab | Chemical compounds |
| JOP20190144A1 (ar) | 2016-12-16 | 2019-06-16 | Janssen Pharmaceutica Nv | إيميدازو بيرولو بيريدين كمثبطات لعائلة jak الخاصة بإنزيمات الكيناز |
| PL3555064T3 (pl) | 2016-12-16 | 2023-03-06 | Pfizer Inc. | Agoności receptora GLP-1 i ich zastosowania |
| US20190281874A1 (en) | 2016-12-16 | 2019-09-19 | Nestec S.A. | Oligosaccharides for flavour generation |
| EP3763717B1 (en) | 2016-12-16 | 2023-03-08 | Eli Lilly And Co. | Pyrido[4,3-d][1,3]oxazin-2-one compounds as mutant idh1 and idh2 inhibitors |
| CN110291072A (zh) | 2016-12-16 | 2019-09-27 | 巴斯夫欧洲公司 | 农药化合物 |
| CA3046965A1 (en) | 2016-12-16 | 2018-06-21 | Janssen Pharmaceutica Nv | Small molecule inhibitors of the jak family of kinases |
| DK3494116T3 (da) | 2017-01-30 | 2020-01-27 | Astrazeneca | Østrogenreceptormodulatorer |
| TWI778050B (zh) | 2017-04-21 | 2022-09-21 | 美商醫肯納腫瘤學公司 | 吲哚ahr抑制劑及其用途 |
| TW202016110A (zh) | 2018-06-15 | 2020-05-01 | 比利時商健生藥品公司 | Ｊａｋ激酶家族之小分子抑制劑 |
| US20200338051A1 (en) | 2019-04-24 | 2020-10-29 | Janssen Pharmaceutica Nv | Non-clinical liquid formulations of pan-jak inhibitor |
-
2017
- 2017-12-15 CA CA3046965A patent/CA3046965A1/en active Pending
- 2017-12-15 LT LTEPPCT/US2017/066744T patent/LT3555097T/lt unknown
- 2017-12-15 UA UAA201908086A patent/UA125042C2/uk unknown
- 2017-12-15 EP EP22178880.5A patent/EP4086256A1/en active Pending
- 2017-12-15 DK DK17854175.1T patent/DK3555097T3/da active
- 2017-12-15 JP JP2019531668A patent/JP7291077B2/ja active Active
- 2017-12-15 HR HRP20220885TT patent/HRP20220885T1/hr unknown
- 2017-12-15 CN CN201780077753.4A patent/CN110088105B/zh active Active
- 2017-12-15 WO PCT/US2017/066744 patent/WO2018112379A1/en active Application Filing
- 2017-12-15 TW TW106144095A patent/TWI777997B/zh active
- 2017-12-15 MD MDE20191212T patent/MD3555097T2/ro unknown
- 2017-12-15 MX MX2019007073A patent/MX2019007073A/es unknown
- 2017-12-15 RS RS20220753A patent/RS63500B1/sr unknown
- 2017-12-15 EP EP17854175.1A patent/EP3555097B1/en active Active
- 2017-12-15 KR KR1020197020121A patent/KR102352462B1/ko active IP Right Grant
- 2017-12-15 CR CR20190282A patent/CR20190282A/es unknown
- 2017-12-15 JO JOP/2019/0143A patent/JOP20190143B1/ar active
- 2017-12-15 MY MYPI2019003389A patent/MY196260A/en unknown
- 2017-12-15 BR BR112019011968-0A patent/BR112019011968A2/pt active Search and Examination
- 2017-12-15 ES ES17854175T patent/ES2922379T3/es active Active
- 2017-12-15 SI SI201731186T patent/SI3555097T1/sl unknown
- 2017-12-15 PE PE2019001252A patent/PE20191105A1/es unknown
- 2017-12-15 PL PL17854175.1T patent/PL3555097T3/pl unknown
- 2017-12-15 MX MX2022004474A patent/MX2022004474A/es unknown
- 2017-12-15 HU HUE17854175A patent/HUE059274T2/hu unknown
- 2017-12-15 US US15/843,642 patent/US10294226B2/en active Active
- 2017-12-15 PT PT178541751T patent/PT3555097T/pt unknown
- 2017-12-15 AU AU2017377069A patent/AU2017377069B2/en active Active
-
2019
- 2019-01-09 US US16/243,874 patent/US10364246B2/en active Active
- 2019-02-12 US US16/274,142 patent/US11059823B2/en active Active
- 2019-02-13 US US16/275,045 patent/US10487083B2/en active Active
- 2019-06-06 PH PH12019501254A patent/PH12019501254A1/en unknown
- 2019-06-12 IL IL267275A patent/IL267275B/en unknown
- 2019-06-12 CL CL2019001626A patent/CL2019001626A1/es unknown
- 2019-06-13 SA SA519402216A patent/SA519402216B1/ar unknown
- 2019-06-14 CO CONC2019/0006200A patent/CO2019006200A2/es unknown
- 2019-06-14 EC ECSENADI201942688A patent/ECSP19042688A/es unknown
- 2019-06-14 NI NI201900060A patent/NI201900060A/es unknown
- 2019-07-15 ZA ZA2019/04615A patent/ZA201904615B/en unknown
-
2020
- 2020-10-21 AU AU2020257068A patent/AU2020257068A1/en not_active Abandoned
-
2021
- 2021-06-23 US US17/355,472 patent/US20210340143A1/en active Pending
-
2022
- 2022-06-17 AU AU2022204240A patent/AU2022204240B2/en active Active
-
2023
- 2023-02-13 JP JP2023019626A patent/JP7493068B2/ja active Active
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RS63500B1 (sr) | Jedinjenja imidazo[4,5-d]pirolo[2,3-b]piridina kao inhibitori janus kinaza | |
| IL277576A (en) | Mutated pyrazolo[1,5-A]pyridine compounds as RET kinase inhibitors | |
| IL265918B (en) | Converted pyrazolo[1,5–a]pyridine compounds as ret kinase inhibitors | |
| HUS2200003I1 (hu) | Pirrolo [2,3-D]pirimidin származékok mint a Janus-kinázok (JAK) inhibitorai | |
| HK1258905A1 (zh) | 作為ret激酶抑制劑的取代的吡唑並[1，5-a]吡啶化合物 | |
| HK1248675A1 (zh) | 調節激酶的1h 吡咯並[2，3-b]吡啶衍生物的合成 | |
| PL3712152T3 (pl) | Pochodne 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pirydyny i 1,4,5,6,7,8-heksahydroimidazo[4,5-d]azepiny jako inhibitory kinaz janusowych | |
| IL266305B (en) | History of [4,2,1]triazolo[5,1-a]pyrimidine as pde2 inhibitors | |
| PL3371185T3 (pl) | Pochodne 4,5,6,7-tetrahydro-1h-imidazo[4,5-c]pirydyny i 1,4,5,6,7,8-heksahydroimidazo[4,5-d]azepiny jako inhibitory kinaz janusowych | |
| EP3856743A4 (en) | SUBSTITUTED IMIDAZO[1,2-A]PYRIDINE AND [1,2,4]TRIAZOLO[1,5-A]PYRIDINE COMPOUNDS AS RET KINASE INHIBITORS |